000			01786 a2200493 4500
005			20250516122138.0
264		0	_c20131105
008			201311s 0 0 eng d
022			_a1463-1326
024	7		_a10.1111/dom.12038 _2doi
040			_aNLM _beng _cNLM
100	1		_aWilding, J P H
245	0	0	_aEfficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _cMay 2013
300			_a403-9 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEurope _xepidemiology
650	0	4	_aFemale
650	0	4	_aGlucosides _xadministration & dosage
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMetformin _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aThiophenes _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
700	1		_aFerrannini, E
700	1		_aFonseca, V A
700	1		_aWilpshaar, W
700	1		_aDhanjal, P
700	1		_aHouzer, A
773	0		_tDiabetes, obesity & metabolism _gvol. 15 _gno. 5 _gp. 403-9
856	4	0	_uhttps://doi.org/10.1111/dom.12038 _zAvailable from publisher's website
999			_c22275503 _d22275503